IBD Scholarship

AbbView IBD Scholarship logo

2025 AbbVie IBD Scholarship

APPLY NOW!

Supporting students with Crohn’s and colitis

The AbbVie IBD Scholarship program helps students with inflammatory bowel disease (IBD) achieve their academic goals while they make a lasting and meaningful difference in their communities. Crohn’s and Colitis Canada will award fifteen (15) aspiring students a one-time $5,000 CAD scholarship to support their education at a Canadian post-secondary institution for the upcoming fall semester. The program helps alleviate financial barriers, enabling students to focus on their studies, pursue their passions, and engage in meaningful community work. Learn more about eligibility and the application requirements below.

Clinton Shard Memorial Scholarship

The Clinton Shard Memorial Scholarship honours the legacy of Clinton Shard, a 2012 AbbVie IBD Scholarship recipient who made significant contributions to the IBD community. Each year, the Shard family selects one scholarship recipient to receive the award. Read more about Clinton Shard and his legacy.

Eligibility requirements

Applicants of any age are encouraged to apply and must be:

  • A citizen or permanent resident of Canada

  • Diagnosed with Crohn’s or colitis by a health care professional

  • Enrolled in or awaiting acceptance from a Canadian university, college, or trade school seeking a diploma, associate, undergraduate, or graduate degree for the upcoming fall semester

  • A student who demonstrates academic aspiration and strives to sustain an optimal level of wellness, balancing their personal health and academic goals

APPLY NOW!
 

The AbbVie IBD Scholarship Program is a competitive process, and applying does not guarantee funding for the upcoming year. Employees of AbbVie or Crohn’s and Colitis Canada and their immediate family members, and past AbbVie IBD Scholarship recipients are not eligible for this scholarship.

How to apply

To apply, you’ll need to submit the following: 
 
  1. A completed online application

  2. Proof of Diagnosis Form, signed by your health care provider

  3. A signed and dated Applicant Consent Form

  4. Two (2) letters of personal recommendation from a teacher, guidance counsellor, school official, coach, mentor, health care provider, professional colleague or employer

  5. A 500-word essay (1 page max.) outlining how you maintain wellness and strive to for academic success, and inspire others through your personal goals and community involvement

    Questions to address:

    • Why do you strive for academic success?

    • How do you maintain an optimal level of wellness?

    • What are your personal and academic goals?

    • How do you inspire others through community and school involvement?

    • How would you benefit from the scholarship financially and psychologically?

We recommend gathering all the necessary information before starting the application process, as you must submit your application in one sitting. You cannot save your progress or return later once you start.

Important dates

  • Applications open on March 27, 2025 
  • Applications are due by June 9, 2025, at 11:59 pm ET 
APPLY NOW!

Selection Process

Scholarship recipients will be selected by an independent committee of leading gastroenterologists, community partners and patient representatives from across Canada. Selection is based on:

Recipients will be notified in the summer/fall of 2025 via phone. Once enrolment is verified for the fall 2025 semester, the scholarship will be deposited directly into their student account to cover tuition and education expenses, including required materials and on-site residency.

Frequently Asked Questions

Supported by

We gratefully acknowledge the supporting organizations that make this scholarship possible: 

logo_AbbVie.gif
CANIBD logo

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest